<i>Limosilactobacillus reuteri</i> regulates gut microbiota and increases the effective metabolite luteolin to inhibit MAPK/STAT3 signaling pathway to alleviate allergic rhinitis.

Front Microbiol · 2025 · PMC11891226 · PMID 40066267

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Furthermore, a marked elevation of IL-10 was observed in the LR group, reaching a highly significant level ( p < 0.0001). 3.3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;i&gt;Limosilactobacillus reuteri&lt;/i&gt; regulates gut microbiota and increases the effective metabolite luteolin to inhibit MAPK/STAT3 signaling pathway to alleviate allergic rhinitis.

The sentences

<i>Limosilactobacillus reuteri</i> regulates gut microbiota and increases the effective metabolite luteolin to inhibit MAPK/STAT3 signaling pathway to alleviate allergic rhinitis.